| Symbol |
Name |
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACVR1
|
activin A receptor, type I
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRB1
|
adrenoceptor beta 1
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ANGPT2
|
angiopoietin 2
|
|
AQP4
|
aquaporin 4
|
|
ARL5A
|
ADP-ribosylation factor-like 5A
|
|
ARL6IP5
|
ADP-ribosylation factor-like 6 interacting protein 5
|
|
ARR3
|
arrestin 3, retinal (X-arrestin)
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN2
|
ataxin 2
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
C9ORF72
|
chromosome 9 open reading frame 72
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBX5
|
chromobox homolog 5
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD177
|
CD177 molecule
|
|
CD28
|
CD28 molecule
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD48
|
CD48 molecule
|
|
CD6
|
CD6 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDC42SE2
|
CDC42 small effector 2
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTGF
|
connective tissue growth factor
|
|
CTSK
|
cathepsin K
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DCD
|
dermcidin
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DLG4
|
discs, large homolog 4 (Drosophila)
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
EZR
|
ezrin
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAM162A
|
family with sequence similarity 162, member A
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCRL3
|
Fc receptor-like 3
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FUS
|
FUS RNA binding protein
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GNAT2
|
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3
|
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3
|
|
HCAR3
|
hydroxycarboxylic acid receptor 3
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST1H1A
|
histone cluster 1, H1a
|
|
HIST1H1C
|
histone cluster 1, H1c
|
|
HIST1H1D
|
histone cluster 1, H1d
|
|
HMOX1
|
heme oxygenase 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL15
|
interleukin 15
|
|
IL1B
|
interleukin 1, beta
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
ILK
|
integrin-linked kinase
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JAG1
|
jagged 1
|
|
JUN
|
jun proto-oncogene
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MIR143
|
microRNA 143
|
|
MIR34A
|
microRNA 34a
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NEFM
|
neurofilament, medium polypeptide
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NRD1
|
nardilysin (N-arginine dibasic convertase)
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARVB
|
parvin, beta
|
|
PAX3
|
paired box 3
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PHB
|
prohibitin
|
|
PI4K2B
|
phosphatidylinositol 4-kinase type 2 beta
|
|
PIK3C2B
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PLD2
|
phospholipase D2
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPP1CC
|
protein phosphatase 1, catalytic subunit, gamma isozyme
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTX3
|
pentraxin 3, long
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RHOA
|
ras homolog family member A
|
|
RHOG
|
ras homolog family member G
|
|
RIT1
|
Ras-like without CAAX 1
|
|
RIT2
|
Ras-like without CAAX 2
|
|
RNLS
|
renalase, FAD-dependent amine oxidase
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RUNX1
|
runt-related transcription factor 1
|
|
SCD5
|
stearoyl-CoA desaturase 5
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SPINK7
|
serine peptidase inhibitor, Kazal type 7 (putative)
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2
|
|
TAB3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3
|
|
TANK
|
TRAF family member-associated NFKB activator
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBK1
|
TANK-binding kinase 1
|
|
TBKBP1
|
TBK1 binding protein 1
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TFF2
|
trefoil factor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THOC1
|
THO complex 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TP53
|
tumor protein p53
|
|
TRPV3
|
transient receptor potential cation channel, subfamily V, member 3
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
VCP
|
valosin containing protein
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VLDLR
|
very low density lipoprotein receptor
|